MASTER DEVELOPMENT AND CLINICAL SUPPLY AGREEMENTMaster Development and Clinical Supply Agreement • March 25th, 2021 • Immunome Inc. • Pharmaceutical preparations • Delaware
This Master Development and Clinical Supply Agreement (the “Agreement”) is entered into as of December 14, 2020 (the “Effective Date”) by and between:
MASTER DEVELOPMENT AND CLINICAL SUPPLY AGREEMENTMaster Development and Clinical Supply Agreement • March 4th, 2019 • Nemus Bioscience, Inc. • Pharmaceutical preparations • Delaware
This Master Development and Clinical Supply Agreement (“Agreement”) is made as of this 25th day of February 2019 (“Effective Date”), by and between Noramco, Inc., a Georgia corporation, with a place of business at [****] (“Noramco”), and NEMUS Bioscience, Inc., a Nevada corporation, with a place of business at [****] (“Client”). Client and Noramco may be referred to herein each as a “Party” or together as the “Parties”, as the context may require.
